Patents by Inventor Björn Walse

Björn Walse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES FOR TREATMENT OF DIABETES
    Publication number: 20210009648
    Abstract: The present disclosure concerns agents and their use in the treatment of endocrine, nutritional and/or metabolic diseases in a mammal. The disclosure furthermore concerns novel peptides.
    Type: Application
    Filed: September 16, 2020
    Publication date: January 14, 2021
    Inventors: Jan Alenfall, Pontus Dunér, Anna Hultgårdh Nilsson, Björn Walse
  • Peptides for treatment of diabetes
    Patent number: 10815283
    Abstract: The present disclosure concerns agents and their use in the treatment of endocrine, nutritional and/or metabolic diseases in a mammal. The disclosure furthermore concerns novel peptides.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: October 27, 2020
    Assignee: Follicum AB
    Inventors: Jan Alenfall, Pontus Dunér, Anna Hultgårdh Nilsson, Björn Walse
  • PEPTIDES FOR TREATMENT OF DIABETES
    Publication number: 20200095297
    Abstract: The present disclosure concerns agents and their use in the treatment of endocrine, nutritional and/or metabolic diseases in a mammal. The disclosure furthermore concerns novel peptides.
    Type: Application
    Filed: October 29, 2019
    Publication date: March 26, 2020
    Inventors: Jan Alenfall, Pontus Dunér, Anna Hultgårdh Nilsson, Björn Walse
  • Synthetic peptides and their use
    Patent number: 9132165
    Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumors.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: September 15, 2015
    Assignee: Pergamum AB
    Inventors: Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
  • Human lactoferrin derived peptides and their use
    Patent number: 8846608
    Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumors.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: September 30, 2014
    Assignee: Pergamum AB
    Inventors: Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
  • NEW SYNTHETIC PEPTIDES AND THEIR USE
    Publication number: 20140031296
    Abstract: The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumours.
    Type: Application
    Filed: January 25, 2012
    Publication date: January 30, 2014
    Applicant: PERGAMUM AB
    Inventors: Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Björn Walse, Bo Svenson
  • Antimicrobial peptides and use thereof
    Patent number: 8076286
    Abstract: The invention relates to a molecule comprising at least the amino acid sequence X1 X2 X3 X4 X5 X6 W X8 X9 X10 wherein X4,6,9 is any amino acid residue, X1 is I, L or V, X2 is not C, X3 is A, E, Q, R or Y, X5 is not R, X8 is I or L, X10 is not H and wherein said molecule have a length of from about 10 to about 100 amino acid residues or an analogue thereof. The invention also relates to compositions comprising said molecule and use of the molecule and/or composition of the invention to combat microorganisms, such as bacteria, viruses, fungi, including yeast, and parasites.
    Type: Grant
    Filed: February 12, 2007
    Date of Patent: December 13, 2011
    Assignee: Dermagen AB
    Inventors: Artur Schmidtchen, Martin Malmsten, Björn Walse
  • NOVEL ANTIMICROBIAL PEPTIDES AND USE THEREOF
    Publication number: 20090312265
    Abstract: The invention relates to a molecule comprising at least the amino acid sequence K X K X1 X2 X K G X wherein X is any amino acid residue X1, and X2 is K or R and wherein said molecule have a length of from about 10 to about 100 amino acid residues or an analogue thereof The invention also relates to compositions comprising said molecule and use of the molecule and/or composition of the invention to combat microorganisms, such as bacteria, viruses, fungi, including yeast, and parasites.
    Type: Application
    Filed: February 12, 2007
    Publication date: December 17, 2009
    Applicant: Dermagen AB
    Inventors: Artur Schmidtchen, Martin Malmsten, Björn Walse